21-hydroxylase deficiency

Not yet reviewed

This information is AI generated and has not yet been reviewed by a specialist physician. AI can make mistakes.

Disease overview

Autosomally recessive inherited disease caused by genetic changes in the CYP21A2 gene in which the missing enzyme leads to overproduction of specific hormones made by the adrenal glands.

Common symptoms

Ambigous genitaliaearly pubertyexcess hair growthshort stature as adults and decreased fertility

When to suspect

  • Recommendation 1

    Newborn screening (available in all 50 states), clinical symptoms, biochemical and genetic testing (FISH)

How to test

  • Recommendation 1

    Newborn screening (available in all 50 states), clinical symptoms, biochemical and genetic testing (FISH)

ZebraMD is partnering with Ambry Genetics for clinical-grade whole genome testing for rare diseases. Ambry accepts insurance. If you don’t have a physician to order this test, join our referral list and our team will reach out.

Treatment

  • Recommendation 1

    Patients take replacement steriods such as glucocorticoids and mineralocorticoids

Primary care

  • Recommendation 1

    Appropriate referral to endocrinologist and continuation of steriod therapy

Further support

Clinical trials

Clinical Trials

Sources

No data available

Interested in learning more about 21-hydroxylase deficiency?

Follow to receive regular updates to the latest research development on this disease via email newsletter.